This release provides a highly extensible, easily configurable means to get data formats that meet a user’s precise requirements.
Waltham, MA (PRWEB) March 19, 2011
OpenClinica, the world’s most popular open source clinical trials software for web-based electronic data capture (EDC) and clinical data management (CDM), will be demonstrating OpenClinica 3.1 Beta 2 at the Drug Information Association (DIA) Annual EuroMeeting March 28-30 in Geneva, Switzerland.
The EuroMeeting attracts more than 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry, contract service organizations, clinical research, regulatory agencies, health ministries, patients’ organizations and universities. This convergence affords attendees the opportunity to network with professional colleagues from around the world.
“The new functionality in 3.1 Beta 2 provides a highly extensible, easily configurable means to get data formats that meet a user’s precise requirements,” said OpenClinica Chief Executive Cal Collins. “We made sure that the software enables the export of all possible data related to a study and its clinical data in this format, and users can use the pre-built transformations or create their own to get to their preferred formats. In 3.1, the export also includes all audit trail, discrepancy, and electronic signature information.”
Because of its open source licensing model, OpenClinica stands alone as the most flexible, cost effective solution for EDC and CDM. The commercial version, OpenClinica Enterprise Edition, offers additional capabilities and support for mission critical data capture and management.
OpenClinica enhances the productivity of clinical trials through commercial open source software. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For more information – including product downloads – visit http://www.openclinica.com or follow @OpenClinica on Twitter.
About the Drug Information Association (DIA)
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related healthcare products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.